Schedule 13D ownership disclosure
ZETA ACQUISITION CORP II
Security class unavailable
Event date: 2021-08-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 346,262
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-21-000981
- Form type
- SC 13D
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Sep 03, 2021
- Reporting period
- Aug 26, 2021
- Description
- Schedule 13D beneficial ownership